Oct 7 (Reuters) - The U.S. Food and Drug Administration

has approved Elanco Animal Health's ( ELAN ) oral drug to

protect dogs against six parasitic infections, the company said

on Monday.

The drug, branded as Credelio Quattro, is a single, monthly

chewable tablet for dogs eight weeks of age or older, the

company said.

The drug is approved for the treatment of flea and tick

infestations, along with roundworm, hookworm and tapeworm

infections. It is also approved to prevent flea infestations and

heartworm disease in dogs.

The company expects to launch the drug in the first quarter

of 2025.

(Reporting by Mariam Sunny in Bengaluru; Editing by Devika

Syamnath)